1. Home
  2. RENX vs MTNB Comparison

RENX vs MTNB Comparison

Compare RENX & MTNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RenX Enterprises Corp. Common Stock

RENX

RenX Enterprises Corp. Common Stock

N/A

Current Price

$1.93

Market Cap

4.7M

Sector

N/A

ML Signal

N/A

Logo Matinas Biopharma Holdings Inc.

MTNB

Matinas Biopharma Holdings Inc.

HOLD

Current Price

$0.30

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RENX
MTNB
Founded
2021
2013
Country
United States
United States
Employees
38
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.7M
5.2M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
RENX
MTNB
Price
$1.93
$0.30
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
51.6K
6.3M
Earning Date
05-22-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
59.84
EPS
N/A
N/A
Revenue
N/A
$119,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.09
$0.23
52 Week High
$3.48
$3.09

Technical Indicators

Market Signals
Indicator
RENX
MTNB
Relative Strength Index (RSI) 43.43 36.73
Support Level $1.76 $0.23
Resistance Level $1.82 $0.66
Average True Range (ATR) 0.12 0.06
MACD -0.03 0.00
Stochastic Oscillator 31.99 34.29

Price Performance

Historical Comparison
RENX
MTNB

About RENX RenX Enterprises Corp. Common Stock

RenX Enterprises Corp is engaged in real property development using purpose-built, prefabricated modules constructed from both wood and steel. The Company's operations mainly focused on the acquisition, entitlement, and development of residential properties in high-growth markets across the United States. These efforts included the direct acquisition of land, strategic investments in real estate entities, and joint venture partnerships targeting green, single-family, and multifamily housing projects. The company operates in four segments: real estate development, technology, compost sales, and logistics. The company generates from the compost sales.

About MTNB Matinas Biopharma Holdings Inc.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Share on Social Networks: